Targeting microvascular impairment in patients with peripheral arterial disease: efficacy of lower limb revascularisation combined with supervised exercise therapy

niversity of the Sunshine Coast0 个研究点目标入组 30 人开始时间: 2016年9月5日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1. Patients scheduled for lower limb revascularisation, including open surgery (e.g. bypass), an endovascular procedure, or a hybrid procedure (e.g. endarterectomy plus angioplasty);
•2. Documented diagnosis of PAD based on symptoms (claudication or critical limb ischaemia), an ABI < 0.90, and imaging evidence of a significant (>50%) stenosis in at least one lower-limb arterial segment;
•3. Stable medication and treatment regimen (>3 months);
•4. Physician-assessed ability to undertake the intervention and exercise testing.

•1.Not able to walk independently prior to revascularisation, or walking capacity is limited by symptoms not related to PAD (including neuropathy);
•2.Have had or are undergoing a significant amputation (e.g. forefoot, leg) that is expected to limit ability to walk independently after surgery;
•3.Exercise testing is contraindicated for reasons such as unstable angina, uncontrolled hypertension (>160/100), limiting venous disease or uncontrolled cardiac dysrhythmias;
•4.Current or planned involvement in a supervised exercise rehabilitation program.

发起方

niversity of the Sunshine Coast